Ionolyte (Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Sodium Acetate Trihydrate)

Ionolyte is used to correct electrolyte disturbances and support fluid balance in various clinical settings.

• Electrolyte depletion: restores magnesium, potassium, sodium and acetate levels to re‑establish normal plasma electrolyte concentrations.
• Hypomagnesemia: provides magnesium chloride to increase serum magnesium in patients with low magnesium.
• Hypokalemia: supplies potassium chloride to raise serum potassium and prevent cardiac arrhythmias.
• Hypovolemia: contributes to plasma volume expansion, aiding circulatory stability during dehydration or blood loss.
• Peri‑operative care: maintains fluid and electrolyte homeostasis during surgery or critical‑care management.

• Ionolyte delivers magnesium, potassium, sodium and acetate ions directly into the bloodstream via intravenous infusion. The magnesium and potassium ions act as cofactors for numerous enzymatic reactions and help stabilize cardiac membrane potentials, while sodium drives extracellular fluid volume and osmotic balance. Acetate is metabolized to bicarbonate, contributing to acid‑base regulation. Together, these ions rapidly correct deficits, expand intravascular volume and support cellular function.

Intravenous administration of Ionolyte may be associated with the following adverse reactions.

Common Side Effects

• Injection site pain: mild discomfort or soreness at the infusion site.
• Transient hypermagnesemia: temporary elevation of serum magnesium levels, usually asymptomatic.
• Mild hyperkalemia: slight increase in serum potassium that resolves with monitoring.
• Fluid overload: signs of excess volume such as peripheral edema.

Serious or Rare Side Effects

• Severe hypermagnesemia: can cause hypotension, respiratory depression or cardiac arrest.
• Life‑threatening hyperkalemia: may lead to arrhythmias or cardiac arrest.
• Anaphylactic reaction: rare hypersensitivity with rash, bronchospasm or hypotension.
• Electrolyte imbalance leading to metabolic acidosis: due to acetate metabolism disturbances.

Before using Ionolyte, clinicians should consider the following precautions to ensure safe administration.

• Assess electrolyte status: verify baseline serum magnesium, potassium, sodium and acid‑base balance.
• Monitor cardiac function: continuous ECG is recommended when correcting severe electrolyte deficits.
• Adjust infusion rate: avoid rapid administration in patients with renal impairment or heart failure.
• Caution in renal dysfunction: reduced clearance may predispose to accumulation of magnesium or potassium.
• Contraindications: do not use in patients with known hypersensitivity to any component.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Ionolyte can interact with certain medications; awareness of these interactions helps prevent complications.

Major Interactions (Avoid)

• Loop diuretics: may exacerbate electrolyte losses, requiring close monitoring.
• Calcium channel blockers: combined hypermagnesemia can potentiate neuromuscular blockade.
• ACE inhibitors/ARBs: risk of hyperkalemia when potassium is supplemented.

Moderate Interactions (Monitor Closely)

• Digoxin: altered potassium levels can affect digoxin toxicity.
• Neuromuscular blocking agents: magnesium may enhance their effects.
• Antacids containing aluminum or magnesium: may increase magnesium load.